Literature DB >> 19372595

Differential expression of microRNAs in mouse liver under aberrant energy metabolic status.

Shengjie Li1, Xi Chen, Hongjie Zhang, Xiangying Liang, Yang Xiang, Chaohui Yu, Ke Zen, Youming Li, Chen-Yu Zhang.   

Abstract

Despite years of effort, exact pathogenesis of nonalcoholic fatty liver disease (NAFLD) remains obscure. To gain an insight into the regulatory roles of microRNAs (miRNAs) in aberrant energy metabolic status and pathogenesis of NAFLD, we analyzed the expression of miRNAs in livers of ob/ob mice, streptozotocin (STZ)-induced type 1 diabetic mice, and normal C57BL/6 mice by miRNA microarray. Compared with normal C57BL/6 mice, ob/ob mice showed upregulation of eight miRNAs and downregulation of four miRNAs in fatty livers. Upregulation of miR-34a and downregulation of miR-122 was found in livers of STZ-induced diabetic mice. These results demonstrate that distinct miRNAs are strongly dysregulated in NAFLD and hyperglycemia. Comparison between miRNA expressions in livers of ob/ob mice and STZ-administered mice further revealed upregulation of four miRNAs and downregulation of two miRNAs in livers of ob/ob mice, indicating that these miRNAs may represent a molecular signature of NAFLD. A distinctive miRNA expression pattern was identified in ob/ob mouse liver, and hierarchical clustering of this pattern could clearly discriminate ob/ob mice from either normal C57BL/6 mice or STZ-administered mice. These findings suggest an important role of miRNAs in hepatic energy metabolism and implicate the participation of miRNAs in the pathophysiological processes of NAFLD.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19372595      PMCID: PMC2724772          DOI: 10.1194/jlr.M800509-JLR200

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  57 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

Review 2.  Nonalcoholic fatty liver disease.

Authors:  Jeanne M Clark; Frederick L Brancati; Anna Mae Diehl
Journal:  Gastroenterology       Date:  2002-05       Impact factor: 22.682

Review 3.  MicroRNAs grow up in the immune system.

Authors:  Kai P Hoefig; Vigo Heissmeyer
Journal:  Curr Opin Immunol       Date:  2008-06-12       Impact factor: 7.486

4.  Studies of the diabetogenic action of streptozotocin.

Authors:  A Junod; A E Lambert; L Orci; R Pictet; A E Gonet; A E Renold
Journal:  Proc Soc Exp Biol Med       Date:  1967-10

5.  Identification of tissue-specific microRNAs from mouse.

Authors:  Mariana Lagos-Quintana; Reinhard Rauhut; Abdullah Yalcin; Jutta Meyer; Winfried Lendeckel; Thomas Tuschl
Journal:  Curr Biol       Date:  2002-04-30       Impact factor: 10.834

6.  Metformin reverses fatty liver disease in obese, leptin-deficient mice.

Authors:  H Z Lin; S Q Yang; C Chuckaree; F Kuhajda; G Ronnet; A M Diehl
Journal:  Nat Med       Date:  2000-09       Impact factor: 53.440

7.  Altered expression of miR-21, miR-31, miR-143 and miR-145 is related to clinicopathologic features of colorectal cancer.

Authors:  O Slaby; M Svoboda; P Fabian; T Smerdova; D Knoflickova; M Bednarikova; R Nenutil; R Vyzula
Journal:  Oncology       Date:  2008-01-15       Impact factor: 2.935

Review 8.  Energizing miRNA research: a review of the role of miRNAs in lipid metabolism, with a prediction that miR-103/107 regulates human metabolic pathways.

Authors:  Bernard R Wilfred; Wang-Xia Wang; Peter T Nelson
Journal:  Mol Genet Metab       Date:  2007-05-22       Impact factor: 4.797

9.  Nonalcoholic steatohepatitis: an expanded clinical entity.

Authors:  B R Bacon; M J Farahvash; C G Janney; B A Neuschwander-Tetri
Journal:  Gastroenterology       Date:  1994-10       Impact factor: 22.682

10.  Effects of leptin deficiency and short-term repletion on hepatic gene expression in genetically obese mice.

Authors:  A W Ferrante; M Thearle; T Liao; R L Leibel
Journal:  Diabetes       Date:  2001-10       Impact factor: 9.461

View more
  70 in total

Review 1.  Post-transcriptional regulation in metabolic diseases.

Authors:  Wook Kim; Eun Kyung Lee
Journal:  RNA Biol       Date:  2012-06-01       Impact factor: 4.652

2.  Behavioral plasticity in honey bees is associated with differences in brain microRNA transcriptome.

Authors:  J K Greenberg; J Xia; X Zhou; S R Thatcher; X Gu; S A Ament; T C Newman; P J Green; W Zhang; G E Robinson; Y Ben-Shahar
Journal:  Genes Brain Behav       Date:  2012-04-06       Impact factor: 3.449

3.  MicroRNAs in hepatic pathophysiology in diabetes.

Authors:  Kirandeep Kaur; Himanshi Bhatia; Malabika Datta
Journal:  World J Diabetes       Date:  2011-10-15

Review 4.  Emerging role of microRNAs in liver diseases.

Authors:  Shashi Bala; Miguel Marcos; Gyongyi Szabo
Journal:  World J Gastroenterol       Date:  2009-12-07       Impact factor: 5.742

5.  High protein/fish oil diet prevents hepatic steatosis in NONcNZO10 mice; association with diet/genetics-regulated micro-RNAs.

Authors:  Nikhil Adi; Jennipher Adi; Roberta Marques Lassance-Soares; Paul Kurlansky; Hong Yu; Keith A Webster
Journal:  J Diabetes Metab       Date:  2016-06-16

Review 6.  Role of miRNAs in the pathogenesis and susceptibility of diabetes mellitus.

Authors:  Naoko Hashimoto; Tomoaki Tanaka
Journal:  J Hum Genet       Date:  2016-12-08       Impact factor: 3.172

7.  A novel inverse relationship between metformin-triggered AMPK-SIRT1 signaling and p53 protein abundance in high glucose-exposed HepG2 cells.

Authors:  Lauren E Nelson; Rudy J Valentine; José M Cacicedo; Marie-Soleil Gauthier; Yasuo Ido; Neil B Ruderman
Journal:  Am J Physiol Cell Physiol       Date:  2012-02-29       Impact factor: 4.249

Review 8.  Regulation of SIRT1 by microRNAs.

Authors:  Sung-E Choi; Jongsook Kim Kemper
Journal:  Mol Cells       Date:  2013-11-06       Impact factor: 5.034

Review 9.  Understanding Genetic Heterogeneity in Type 2 Diabetes by Delineating Physiological Phenotypes: SIRT1 and its Gene Network in Impaired Insulin Secretion.

Authors:  Shafat Ali; Shazia Nafis; Ponnusamy Kalaiarasan; Ekta Rai; Swarkar Sharma; Rameshwar N Bamezai
Journal:  Rev Diabet Stud       Date:  2016-05-10

10.  Inhibition of mitochondrial β-oxidation by miR-107 promotes hepatic lipid accumulation and impairs glucose tolerance in vivo.

Authors:  H Bhatia; B R Pattnaik; M Datta
Journal:  Int J Obes (Lond)       Date:  2015-10-26       Impact factor: 5.095

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.